244 related articles for article (PubMed ID: 25395170)
1. CSN6 drives carcinogenesis by positively regulating Myc stability.
Chen J; Shin JH; Zhao R; Phan L; Wang H; Xue Y; Post SM; Ho Choi H; Chen JS; Wang E; Zhou Z; Tseng C; Gully C; Velazquez-Torres G; Fuentes-Mattei E; Yeung G; Qiao Y; Chou PC; Su CH; Hsieh YC; Hsu SL; Ohshiro K; Shaikenov T; Wang H; Yeung SC; Lee MH
Nat Commun; 2014 Nov; 5():5384. PubMed ID: 25395170
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of the COP9 signalosome-cullin-RING ubiquitin-ligase pathway: mechanisms and roles in urological cancers.
Gummlich L; Rabien A; Jung K; Dubiel W
Int J Biochem Cell Biol; 2013 Jul; 45(7):1327-37. PubMed ID: 23583660
[TBL] [Abstract][Full Text] [Related]
3. CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR.
Hou J; Deng Q; Zhou J; Zou J; Zhang Y; Tan P; Zhang W; Cui H
Oncogene; 2017 Feb; 36(8):1134-1144. PubMed ID: 27546621
[TBL] [Abstract][Full Text] [Related]
4. Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axis.
Choi HH; Guma S; Fang L; Phan L; Ivan C; Baggerly K; Sood A; Lee MH
Cell Cycle; 2015; 14(14):2265-73. PubMed ID: 25945542
[TBL] [Abstract][Full Text] [Related]
5. Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers.
Zhao R; Yeung SC; Chen J; Iwakuma T; Su CH; Chen B; Qu C; Zhang F; Chen YT; Lin YL; Lee DF; Jin F; Zhu R; Shaikenov T; Sarbassov D; Sahin A; Wang H; Wang H; Lai CC; Tsai FJ; Lozano G; Lee MH
J Clin Invest; 2011 Mar; 121(3):851-65. PubMed ID: 21317535
[TBL] [Abstract][Full Text] [Related]
6. Quercetin-induced apoptosis of HT-29 colon cancer cells via inhibition of the Akt-CSN6-Myc signaling axis.
Yang L; Liu Y; Wang M; Qian Y; Dong X; Gu H; Wang H; Guo S; Hisamitsu T
Mol Med Rep; 2016 Nov; 14(5):4559-4566. PubMed ID: 27748879
[TBL] [Abstract][Full Text] [Related]
7. CSN6 promotes the cell migration of breast cancer cells by positively regulating Snail1 stability.
Mou J; Wei L; Liang J; Du W; Pei D
Int J Med Sci; 2020; 17(17):2809-2818. PubMed ID: 33162808
[No Abstract] [Full Text] [Related]
8. Post-transcriptional fine-tuning of COP9 signalosome subunit biosynthesis is regulated by the c-Myc/Lin28B/let-7 pathway.
Leppert U; Henke W; Huang X; Müller JM; Dubiel W
J Mol Biol; 2011 Jun; 409(5):710-21. PubMed ID: 21530537
[TBL] [Abstract][Full Text] [Related]
9. The COP9 signalosome-mediated deneddylation is stimulated by caspases during apoptosis.
Hetfeld BK; Peth A; Sun XM; Henklein P; Cohen GM; Dubiel W
Apoptosis; 2008 Feb; 13(2):187-95. PubMed ID: 18060501
[TBL] [Abstract][Full Text] [Related]
10. The COP9 signalosome subunit 6 (CSN6): a potential oncogene.
Zhang SN; Pei DS; Zheng JN
Cell Div; 2013 Nov; 8(1):14. PubMed ID: 24286178
[TBL] [Abstract][Full Text] [Related]
11. CSN6 Promotes the Migration and Invasion of Cervical Cancer Cells by Inhibiting Autophagic Degradation of Cathepsin L.
Mao Z; Sang MM; Chen C; Zhu WT; Gong YS; Pei DS
Int J Biol Sci; 2019; 15(6):1310-1324. PubMed ID: 31223289
[TBL] [Abstract][Full Text] [Related]
12. Protection of cullin-RING E3 ligases by CSN-UBP12.
Wu JT; Chan YR; Chien CT
Trends Cell Biol; 2006 Jul; 16(7):362-9. PubMed ID: 16762551
[TBL] [Abstract][Full Text] [Related]
13. COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3σ.
Choi HH; Gully C; Su CH; Velazquez-Torres G; Chou PC; Tseng C; Zhao R; Phan L; Shaiken T; Chen J; Yeung SC; Lee MH
Oncogene; 2011 Dec; 30(48):4791-801. PubMed ID: 21625211
[TBL] [Abstract][Full Text] [Related]
14. CSN6 positively regulates c-Jun in a MEKK1-dependent manner.
Shin J; Phan L; Chen J; Lu Z; Lee MH
Cell Cycle; 2015; 14(19):3079-87. PubMed ID: 26237449
[TBL] [Abstract][Full Text] [Related]
15. COP9 signalosome subunit 6 (CSN6) regulates E6AP/UBE3A in cervical cancer.
Gao S; Fang L; Phan LM; Qdaisat A; Yeung SC; Lee MH
Oncotarget; 2015 Sep; 6(29):28026-41. PubMed ID: 26318036
[TBL] [Abstract][Full Text] [Related]
16. Targeting the COP9 signalosome for cancer therapy.
Du W; Zhang R; Muhammad B; Pei D
Cancer Biol Med; 2022 Mar; 19(5):573-90. PubMed ID: 35315259
[TBL] [Abstract][Full Text] [Related]
17. The Emerging Role of CSN6 in Biological Behavior and Cancer Progress.
Mao Z; Chen C; Pei DS
Anticancer Agents Med Chem; 2019; 19(10):1198-1204. PubMed ID: 30961513
[TBL] [Abstract][Full Text] [Related]
18. Association of SAP130/SF3b-3 with Cullin-RING ubiquitin ligase complexes and its regulation by the COP9 signalosome.
Menon S; Tsuge T; Dohmae N; Takio K; Wei N
BMC Biochem; 2008 Jan; 9():1. PubMed ID: 18173839
[TBL] [Abstract][Full Text] [Related]
19. CSN6 promotes melanoma proliferation and metastasis by controlling the UBR5-mediated ubiquitination and degradation of CDK9.
Zhang Y; Hou J; Shi S; Du J; Liu Y; Huang P; Li Q; Liu L; Hu H; Ji Y; Guo L; Shi Y; Liu Y; Cui H
Cell Death Dis; 2021 Jan; 12(1):118. PubMed ID: 33483464
[TBL] [Abstract][Full Text] [Related]
20. Targeted silencing of Jab1/Csn5 in human cells downregulates SCF activity through reduction of F-box protein levels.
Cope GA; Deshaies RJ
BMC Biochem; 2006 Jan; 7():1. PubMed ID: 16401342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
